Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) – Investment analysts at SunTrust Banks raised their Q3 2017 earnings estimates for Ekso Bionics Holdings in a note issued to investors on Monday. SunTrust Banks analyst B. Nudell now forecasts that the company will post earnings of ($0.13) per share for the quarter, up from their prior forecast of ($0.15). SunTrust Banks also issued estimates for Ekso Bionics Holdings’ FY2017 earnings at ($0.64) EPS, FY2018 earnings at ($0.32) EPS and FY2021 earnings at ($0.17) EPS.

Ekso Bionics Holdings (NASDAQ:EKSO) last issued its quarterly earnings results on Tuesday, May 9th. The company reported ($0.38) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.03. The company had revenue of $1.44 million for the quarter, compared to the consensus estimate of $2.38 million. Ekso Bionics Holdings had a negative return on equity of 798.93% and a negative net margin of 372.20%.

WARNING: “Q3 2017 Earnings Forecast for Ekso Bionics Holdings, Inc. (EKSO) Issued By SunTrust Banks” was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another website, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this article can be viewed at https://www.watchlistnews.com/q3-2017-earnings-forecast-for-ekso-bionics-holdings-inc-ekso-issued-by-suntrust-banks/1467278.html.

Several other brokerages have also recently issued reports on EKSO. Zacks Investment Research cut Ekso Bionics Holdings from a “buy” rating to a “hold” rating in a research report on Friday, June 16th. B. Riley restated a “buy” rating and issued a $4.00 price target on shares of Ekso Bionics Holdings in a research report on Wednesday, May 10th.

Ekso Bionics Holdings (NASDAQ:EKSO) opened at 1.84 on Thursday. The stock’s market cap is $47.17 million. Ekso Bionics Holdings has a 12 month low of $0.99 and a 12 month high of $6.38. The firm’s 50-day moving average price is $2.02 and its 200-day moving average price is $2.67.

Institutional investors have recently added to or reduced their stakes in the company. National Planning Corp boosted its position in Ekso Bionics Holdings by 116.2% in the second quarter. National Planning Corp now owns 234,450 shares of the company’s stock valued at $537,000 after buying an additional 126,000 shares during the last quarter. Carl Domino Inc boosted its position in Ekso Bionics Holdings by 74.7% in the second quarter. Carl Domino Inc now owns 82,054 shares of the company’s stock valued at $190,000 after buying an additional 35,088 shares during the last quarter. Finally, Independence Advisors LLC acquired a new position in Ekso Bionics Holdings during the second quarter valued at about $1,840,000. Institutional investors own 4.55% of the company’s stock.

Earnings History and Estimates for Ekso Bionics Holdings (NASDAQ:EKSO)

Receive News & Ratings for Ekso Bionics Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.